SALT LAKE CITY, Aug. 31, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Mark C. Capone, President of Myriad Genetic Laboratories, Inc., is scheduled to present at the UBS Global Life Sciences Conference, at 1:30 p.m. Eastern on September 21, 2010, at the Grand Hyatt Hotel in New York City, and that Peter D. Meldrum, President and CEO, is scheduled to present at the Fifth Annual JMP Securities Healthcare Conference, at 11:30 a.m. Eastern on September 28, 2010, at the New York Palace Hotel in New York City.
